6-28515727-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182701.1(GPX6):c.17A>T(p.Gln6Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_182701.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPX6 | NM_182701.1 | c.17A>T | p.Gln6Leu | missense_variant | 1/5 | ENST00000361902.5 | NP_874360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPX6 | ENST00000361902.5 | c.17A>T | p.Gln6Leu | missense_variant | 1/5 | 1 | NM_182701.1 | ENSP00000354581 | P1 | |
GPX6 | ENST00000474923.1 | c.17A>T | p.Gln6Leu | missense_variant | 1/4 | 1 | ENSP00000417364 | |||
GPX6 | ENST00000483058.1 | n.307-4823A>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249538Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135400
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461490Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727080
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2023 | The c.17A>T (p.Q6L) alteration is located in exon 1 (coding exon 1) of the GPX6 gene. This alteration results from a A to T substitution at nucleotide position 17, causing the glutamine (Q) at amino acid position 6 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at